Australia markets closed

Cochlear Limited (COH.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
330.39-8.51 (-2.51%)
At close: 04:10PM AEST

Cochlear Limited

1 University Avenue
Macquarie University
Sydney, NSW 2109
61 2 9428 6555

IndustryMedical Devices
Full-time employees4,800

Key executives

NameTitlePayExercisedYear born
Mr. Diggory William Howitt BE (Hons), MBACEO, MD, President & Executive Director4.78MN/A1967
Mr. Stuart SayersChief Financial Officer1.87MN/AN/A
Mr. Jan Janssen MSc Elec EngChief Technology Officer2.04MN/A1965
Ms. Karen O'DriscollChief Information OfficerN/AN/AN/A
Ms. Kristina DevonVice President of Investor RelationsN/AN/AN/A
Mr. Rob McGroryGroup General Counsel & Company SecretaryN/AN/AN/A
Ms. Jennifer StevensonVP of Corporate Communications & BrandN/AN/AN/A
Mr. Dean PhizackleaSenior Vice President of Global Strategic MarketingN/AN/AN/A
Ms. Jennifer HornerySenior Vice President of Global People & CultureN/AN/AN/A
Mr. Greg Bodkin BE (Hons), MComm (UNSW)Senior Vice President of Global Supply ChainN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Corporate governance

Cochlear Limited’s ISS governance QualityScore as of 1 May 2024 is 1. The pillar scores are Audit: 1; Board: 1; Shareholder rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.